Transplacental Pharmacokinetics of Glyburide, Rhodamine 123, and BODIPY FL Prazosin: Effect of Drug Efflux Transporters and Lipid Solubility
Open Access
- 24 September 2009
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in The Journal of pharmacology and experimental therapeutics
- Vol. 331 (3), 1118-1125
- https://doi.org/10.1124/jpet.109.160564
Abstract
Breast cancer resistance protein (BCRP) and P-glycoprotein (P-gp) are the most abundantly expressed ATP-binding cassette (ABC) drug transporters in the placenta. They recognize a large, partly overlapping spectrum of chemically unrelated compounds and affect their transplacental passage. In this study we investigate the effect of Bcrp and P-gp on the transplacental pharmacokinetics of their specific and common substrates employing the technique of dually perfused rat placenta. We show that the clearance of rhodamine 123 (P-gp substrate), glyburide (BCRP substrate) and BODIPY FL prazosin (P-gp and BCRP substrate) in fetal-to-maternal direction is 11, 11.2 and 4 times higher, respectively, than that in the maternal-to-fetal direction. In addition, all of these substances were found to be transported from the fetal compartment even against concentration gradient. We thus demonstrate the ability of placental ABC transporters to hinder maternal-to-fetal and accelerate fetal-to-maternal transport in a concentration-dependent manner. However, by means of pharmacokinetic modeling we describe the inverse correlation between lipid solubility of a molecule and its active transport by placental ABC efflux transporters. Therefore, in the case of highly lipophilic substrates, such as BODIPY FL prazosin in this study, the efficacy of efflux transporters to pump the molecule back to the maternal circulation is markedly limited.This publication has 40 references indexed in Scilit:
- Role of breast cancer resistance protein (Bcrp/Abcg2) in fetal protection during gestation in ratToxicology Letters, 2008
- P-glycoprotein in the placenta: Expression, localization, regulation and functionReproductive Toxicology, 2006
- Use of prescription medications with a potential for fetal harm among pregnant womenPharmacoepidemiology and Drug Safety, 2006
- EXPRESSION AND FUNCTIONAL ACTIVITY OF BREAST CANCER RESISTANCE PROTEIN (BCRP, ABCG2) TRANSPORTER IN THE HUMAN CHORIOCARCINOMA CELL LINE BEWOClinical and Experimental Pharmacology and Physiology, 2006
- Prescription drug use in pregnancyAmerican Journal of Obstetrics and Gynecology, 2004
- Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXRCancer Letters, 1999
- A multidrug resistance transporter from human MCF-7 breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 1998
- Comparative placental transport of oral hypoglycemic agents in humans: A model of human placental drug transferAmerican Journal of Obstetrics and Gynecology, 1994
- Quantitative expression patterns of multidrug‐resistance P‐glycoprotein (MDR1) and differentially spliced cystic‐fibrosis transmembrane‐conductance regulator mRNA transcripts in human epitheliaJBIC Journal of Biological Inorganic Chemistry, 1992
- Insignificant transfer of glyburide occurs across the human placentaAmerican Journal of Obstetrics and Gynecology, 1991